|
|
Publications by Marc F. Goldstein, MD
Journal Articles:
1.Goldstein MF, Nestico P, Olshan A, and Schwartz A. Superior Vena Cava Thrombosis and Pulmonary Embolus Associated with Right Atrial Mural Thrombus. Arch Intern Med 1982; 142:1726-1728
2.Goldstein MF, Johnson BE, Steadt J, et al. Congenitally Corrected Transposition of the Great Vessels Complicated by Constrictive Pericarditis: A Case Report. Am J Med Sci 1983; 285:27-31
3.Goldstein MF, Hoxie J, Zembryki D, Matthew D, Levinson AI. Phenotypic and Functional Analysis of B Cell Lines From Patients with Multiple Myeloma. Blood 1985; 66:444-446
4.Campbell FW, Goldstein MF, Tabka C. Management of the Patient with Protamine Hypersensitivity for Cardiac Surgery. Anesthesiology 1984; 61:761-764
5.Cohen FC, Goldstein MF, Zweiman B. Skin Testing in Chymopapain Anaphylaxis. J Allergy Clin Immunol 1985; 75:728-730
6.Goldstein MF, Kornstein MK, Levinson AI. Acquired Hyper-IgM Syndrome with Necrotizing Granuloma. J Allergy Clin Immunol 1985; 75: 472-478
7.Goldstein MF, Cogan FC, Atkins PA, et al. Allergic Aspergillus Sinusitis. J Allergy Clin Immunol 1985; 76:515-524
8.Goldstein MF, Zweiman B, Freeman M. Eosinophilic Fascitis-Atypical Features. Cutis 1987; 39: 214-216
9.Goldstein MF. Allergic Fungal Sinusitis: An Underdiagnosed Problem. Hospital Practice 1992; 27(6):73-92
10.Goldstein MF, Dvorin DJ, Dunsky EH, Lesser RW, Heuman PJ, and Loose JH. Allergy Grand Rounds: Allergic Rhizomucor Sinusitis. J Allergy Clin Immunol 1992; 90(3):394-404
11.Goldstein MF, Dunsky EH, Dvorin DJ, and Lesser RW. Allergic Fungal Sinusitis: A Review with 4 Illustrated Cases. Am J Rhinology 1994; 8(1):13-18
12.Goldstein MF, Pacana SM, Dvorin DJ, and Dunsky EH. Retrospective Analyses of Methacholine Inhalation Challenges. CHEST 1994; 105(4):1082-1088
13.Kemp JP, Pearlman DS, Tinkelman DG, et al. An evaluation of the efficacy and safety of azelastine in patients with chronic asthma. J Allergy Clin Immunol 1996; 97(6):1218-1224
14.Condemi JJ, Chervinsky P, Goldstein MF, et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol 1997; 100:467-474
15.Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, et al. Comparative efficacy and safety of twice-daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol 1997; 78:356-362
16.Li J, Oschur S, Noonan M, Goldstein M, et al. A Comparison of Commonly-Prescribed Doses of Inhaled Fluticasone Propionate (FP) and Inhaled Triamcinolone Acetonide (TAA) on HPA Axis Function. Am J Crit Care Med 1998; 157(3):A407
17.Goldstein MF, Grundfast SK, Dunsky ED, et al. Effect of Functional Endoscopic Sinus Surgery on Bronchial Asthma Outcomes. Arch Otolaryngol Head Neck Surg 1999; 125(3):314-319
18.LaForce C, Goldstein M, Storms W, et al. Comparison of inhaled fluticasone propionate (FP) and flunisolide (FLN) effects on the HPA axis as assessed by 6-hour cosyntopin infusion testing. Accepted for publication, Clinical Therapeutics
19.Storms W, Howland WC, Sorkness CA, LaForce C, Goldstein M, et al. Fluticasone Propionate (FP), Triamcinolone Acetonide (TAA) and Flunisolide (FLN) Have Similar Effects On the HPA Axis. Accepted for publication, Clinical Therapeutics
20.Li JT, Goldstein MF, Gross GN, et al. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the HPA axis. J Allergy Clin Immunol 1999; 103(4):622-629
21.Goldstein MF, Horning R, and Fallon J. Chronic glucosteroid therapy induced osteoporosis in patients with obstructive lung disease. CHEST 1999; 116(6):1733-1749
22.Goldstein MF, Veza BA, Dunsky EH, et al. Comparisons of Peak Diurnal Expiratory Flow Variation, Postbronchodilator FEV1 Responses, and Methacholine Inhalation Challenges in the Evaluation of Suspected Asthma. CHEST 2001; 119(4):1001-1010
23.Dvorin DJ, Lee JJ, Goldstein MF, et al. A Comparative, Volumetric Survey of Airborne Pollen in Philadelphia, Pennsylvania (1991-1997) and Cherry Hill, New Jersey (1995-1997). Ann Allergy Asthma Immunol 2001; 87:394-404
24.Goldstein MF, Veza BA, Lauf-Goldstein A, et al. Forced Expiratory Time and Bronchial Hyperresponsiveness to Methacholine. J Asthma 2002; 39(2):143-150
25.Goldstein MF and Chervinsky P. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma – a double-blind randomized placebo-controlled multicentre clinical trial. Med Sci Monit 2002; 8(4):CR297-304
26.Goldstein MF, Anoia J and Black M. Montelukast-Induced Hepatitis. Annals of Internal Medicine; 140(7):586-587
27.Goldstein M. Efficacy and Safety of Doxofylline in Chronic Asthma. Journal of Asthma, Allergy and Clinical Immunology (Korean Society of Allergology); 24(Supp. II):S98-S103
Abstracts:
1.Goldstein MF, Hoxie J, Zembryki D, Matthew D, and Levinson AI. Phenotypic and Functional Analysis of Malignant B Cell Lines. Blood 1983; 62:190a
2.Cohen KR, Emmons KM, and Goldstein MF. Naloxone Treatment of Toxic Shock Syndrome. Arch Intern Med 1983; 143:1072
3.Goldstein MF, Zembryki D, and Levinson AI. Monocyte Modulation of a Human B Cell Line. Clin Research 1984; 34:700a
4.Goldstein MF, Kornstein M, and Levinson AI. Acquired Hyper-IgM Syndrome and Necrotizing Granuloma. J Allergy Clin Immunol 1984; 73:167
5.Cogen F, Goldstein MF, and Zweiman B. Skin tests in Chymopapain Anaphylaxis. J Allergy Clin Immunol 1984; 73:179
6.Ferrer R, Goldstein MF, Dunsky EH, and Dvorin DJ. “Effects of Terfenadine on Spirometry and Histamine Inhalation challenge” oral presentation, First IUIS Conference on Clinical Immunology, 1986, Toronto, Canada
7.Goldstein MF. Flexibility for ear exam. Consultant. 1987;129
8.Dvorin DJ, Goldstein MF, and Dunsky EH. Uni-Dur v. Slo-Bid—Comparison of Dosage and Efficacy in Childhood Asthma. J Allergy Clin Immunol 1990; 85(2):146
9.Reed CE, Aaronson DW, Bahna SL, Kanuga JG, Berman BA, Goldstein MF, Samuels LL, Lawrence VJW, and Settipane GA. Comparison of Cetirizine and Astemizole Treatment of Seasonal Allergic Rhinitis. Ann Allergy 1991; 66(1):104
10.Wolfe J, Hampel F, Goldstein MF, Mendelson L, Munk Z, Schaberg A, Kral K, and Kellerman D. Efficacy and Safety of Fluticasone Propionate (FP) Metered Dose Inhaler in Patients with Moderate Asthma. J Allergy Clin Immunol 1993; 93(2):186
11.Sekora D, O’Connell K, Goldstein MF, and Harning R. A Long Term Efficacy and Safety Study of Maxivent (Doxofylline) for the Treatment of Chronic Reversible Asthma. J Allergy Clin Immunol 1993; 93(2):295
12.Kemp J, Grady J, Black K, Dockhorn R, Goldstein MF, Grossman J, Morris R, Liddle R, Arledge T, and Reilly D. Salmeterol Powder Provides Greater Control of Asthma than does Albuterol Aerosol. J Allergy Clin Immunol 1995; 95(2):264
13.Pearlman D, Noonan M, Tashkin D, Goldstein M, Hamedani A, Okamoto L, Schaberg A, and Kellerman D. Efficacy of Inhaled Fluticasone Propionate (FP) Powder in Asthma. J Allergy Clin Immunol 1995; 95(2):313
14.Storms W, Friedman B, Zhang K, Santanello N, Allegar N, Apell M, Beacher W, Bronsky E, Busse W, Chervinsky P, Dockhorn R, Edwards B, Goldstein M, Grossman J, Hendeles L, Kemp J, Memon N, Noonan M, Owens G, Shapiro G, Spirn I, Strek M, Stricker W, Tinkelman D, Townley R, Wanderer A, Weisberg S, Winder J, and Woehler T. Treating Asthma by Blocking the Lipoxygenase Pathway. Poster Presentation, American Thoracic Society Internationl Conference in Seattle, WA, May 1995
15.Spector S, Pleskow WW, Goldstein MF, Mullarkey MF, Yancer SW, Wisniewski M, and Richard KA. Salmeterol compared with Theophylline in the Treatment of Asthma. Presentation, AAAAI/ATS combined meeting, “Asthma 1995: Theory to Treatment,” Chicago, IL, July 1995
16.Mahajan P, Okamoto L, Schaumberg J, and Goldstein MF. Patients Satisfaction with a Multi-dose Powder Inhaler (MDPI) Device in treatment of asthma. J Allergy Clin Immunol 1996; 97(1, part 3):249
17.Dvorin DJ, Belecanech GA, Goldstein MF, and Dunsky EH. Survey of Pollens and Mold Spores in Southern New Jersey, 1995-1997. Annals of Allergy, Asthma, and Immunology 1999; 82(1):120
18.Belecanech GA, Dvorin DJ, Goldstein MF, and Dunsky EH. Pollen Seasons in the City of Philadelphia. Annals of Allergy, Asthma, and Immunology 1999; 82(1):121
19.Goldstein MF, Ackerman TS, Lauf-Goldstein A, et al. Forced Expiratory Time and Bronchial Hyperresponsiveness to Methacholine. Annals of Allergy, Asthma, and Immunology 1999; 82(1):52
20.Belecanech GA, Dvorin DJ, Goldstein MF, and Dunsky EH. Outdoor Mold Spore Levels in Philadelphia. J Allergy Clin Immunol 1999; 103(No. 1, Part 2):600
21.Dvorin DJ, Belecanech GA, Goldstein MF, and Dunsky EH. Comparisons of Pollen Surveys between Philadelphia and Southern New Jersey, 1995-1997. J Allergy Clin Immunol 1999; 103(No. 1, Part 2):336
22.Goldstein MF, Banov C, Lilias B, Walton-Bowen K, and Hempel F. Once-Daily Budesonide (Pulmicort Turbuhaler) Improves Quality of Life in Adult Asthmatics Previously Treated with Inhaled Corticosteroids. American College of Allergy, Asthma, and Immunology meeting, abstract publications, 1999
23.Goldstein M and Chervinsky P. Efficacy and Safety of Doxofylline Compared to Theophylline in Chronic Reversible Asthma. A Double-Blind Randomized Placebo-Controlled Multicentre Clinical Trial. Interasma 2002 – XVII World Congress of Asthma
Books and Monographs:
1.Dunsky EH, Goldstein MF, and Dvorin DJ. “Bronchial Asthma and Common Allergic Diseases” in Core Textbook of Pedatrics, 3rd Edition, ed. Kaye R, Oski FA, and Barness LA. JB Lippincott, Philadelphia, PA, 1988
2.Dunsky EH, Goldstein MF, and Dvorin DJ. Common Allergic Diseases: Current Concepts and Medical Management with Special Emphasis on the Use of Antihistamines. In monograph, 1989
3.Dunsky EH, Goldstein MF, Dvorin DJ, et al. Understanding Asthma: The Asthma Center Manual. In monograph, 1990, 1995, 1999
|
